Compositions and methods for topical application and transdermal delivery of botulinum toxins

Details for Australian Patent Application No. 2011202928 (hide)

Owner Revance Therapeutics, Inc.

Inventors Dake, Michael D.; Waugh, Jacob M.

Agent Spruson & Ferguson

Pub. Number AU-A-2011202928

Parent 2005218665

Filing date 17 June 2011

Wipo publication date 7 July 2011

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 8/64 (2006.01) Cosmetics or similar toilet preparations

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61Q 19/08 (2006.01) Preparations for care of the skin - Anti-ageing preparations

Event Publications

7 July 2011 Application Open to Public Inspection

  Published as AU-A-2011202928

7 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202929-System and method of network data acess management

2011202927-Articulating clip applier cartridge